Allegria Therapeutics AG
PrivateLast Round
Seed
Dec 11, 2025
Total Funding Raised
$8.6M
Company Overview
Allegria Therapeutics AG is a biotechnology company that develops proprietary therapeutic approaches and biological targets to selectively modulate mast cells for the treatment of allergy and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allegria Therapeutics AG Comparables
Compare Allegria Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MC Sciences | 83% | |
| IgGenix | 78% | |
| Mabylon AG | 78% | |
Allegria Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 11, 2025 | ||||
| Seed | May 6, 2024 |
Key People
Founding team and executive leadership
Allegria Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Seed |
| Forty51 Ventures | Seed |
| Lichtsteiner Foundation | Seed |
Allegria Therapeutics AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allegria Therapeutics AG's valuation, stock price, and market status.